Drug Type Small molecule drug |
Synonyms 5-10 Methylenetetrahydrofolate, 5-FU biomodulator, CoFactor + [3] |
Target |
Action inhibitors |
Mechanism TYMS inhibitors(Thymidylate synthase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H23CaN7O6 |
InChIKeyXTTQVUYZSJQXLP-ZEDZUCNESA-N |
CAS Registry133978-75-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Phase 3 | United States | 01 May 2006 | |
Colonic Cancer | Phase 3 | Montenegro | 01 May 2006 | |
Metastatic Colorectal Carcinoma | Phase 3 | United States | 01 May 2006 | |
Metastatic Colorectal Carcinoma | Phase 3 | Montenegro | 01 May 2006 | |
Rectal Cancer | Phase 3 | United States | 01 May 2006 | |
Rectal Cancer | Phase 3 | Montenegro | 01 May 2006 | |
Advanced breast cancer | Phase 2 | Argentina | 01 Feb 2006 | |
Advanced breast cancer | Phase 2 | Mexico | 01 Feb 2006 | |
Advanced breast cancer | Phase 2 | Peru | 01 Feb 2006 | |
Advanced breast cancer | Phase 2 | Russia | 01 Feb 2006 |
Phase 2 | - | yhzpfupkeb(ytoyudghfw) = xpaxcaedjn cgbjxbrleg (qakkjziszj ) | - | 20 May 2008 | |||
Phase 2 | Metastatic Colorectal Carcinoma First line | 50 | ihhncxyotc(pjtrotynkj) = median survival has not been reached jvbtisqizh (fjnzeytkys ) | - | 20 Jun 2006 |